Read More

Remitly To Acquire Rewire For ~$80M

Remitly and Rewire share a commitment to transform the lives of millions of immigrants and their families with the most trusted and innovative financial services products. Remitly Global, Inc., (NASDAQ:RELY)

RELY

Read More

Gilead Announced Monday it Would Acquire Remaining Worldwide Rights of Trodelvy from Everest Medicines for $280M Upfront Plus Up to $175M in Milestones

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for Trodelvy® (sacituzumab govitecan) in Greater China, South Korea, Singapore, Indonesia, Philippines, Vietnam, Thailand, Malaysia and Mongolia.

GILD